logo-loader
viewReNeuron Group PLC

ReNeuron inks University of Cardiff collaboration

The venture will utilise ReNeuron's exosome-based drug delivery technology

brain scan
The Cardiff team will attempt to develop systems to deliver nucleic acids, such as small interfering RNA across the blood-brain barrier

ReNeuron Group PLC (LON:RENE) is teaming up with the University of Cardiff to find a method of delivering cancer treatments across the blood-brain barrier.

Work will be funded via a £250,000 grant from Innovate UK's Knowledge Transfer Partnership.

Taking part in the pioneering collaboration will be scientists from the university’s European Cancer Stem Cell Research Institute and the team will utilise ReNeuron's exosome-based drug delivery technology.

Exosomes are nanoparticles released by cells and contain a number of active proteins and micro RNAs that are believed to play a key role in cell-to-cell communication.

A growing body of evidence has demonstrated that exosomes can modulate cellular immunity and promote the activation of regenerative or repair programmes in diseased or injured cells.

The Cardiff collaboration will attempt to develop systems to deliver nucleic acids, such as small interfering RNA (siRNA), across the blood-brain barrier.

siRNAs, also known as silencing RNAs, offer the potential for targeted treatment of certain strains of cancer.

“We are very excited about the potential of our exosome technology platform to deliver therapeutic compounds to the brain and thereby to make a real step-change in the development of treatments against hard-to-target disorders of the central nervous system," said Dr Randolph Corteling, head of research at ReNeuron.

Quick facts: ReNeuron Group PLC

Price: 132.5 GBX

LSE:RENE
Market: LSE
Market Cap: £42.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of ReNeuron Group PLC named herein, including the promotion by the Company of ReNeuron Group PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: Canadian Overseas Petroleum's Millholland to provide...

Headlines from the Proactive UK newsroom. Canadian Overseas Petroleum Limited (LON:COPL) is to receive C$200,000 as a loan from its chief executive, Arthur Millholland, so that it can continue discussions with investors and service providers over plans for the OPL 226 asset. The loan will...

1 week, 1 day ago

2 min read